|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| A61P 35/00 | |||
| C07K 16/28 |
| (11) | Patento numeris | 2567709 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12188230.2 |
| Europos patento paraiškos padavimo data | 2008-10-31 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-03-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-12-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 984827 P | 2007-11-02 | US |
| (72) |
Cong, Feng, US
Rangwala, Shamina M., US
Ettenberg, Seth, US
Guth, Sabine, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6) |
| Molecules and methods for modulating low-density-lipoprotein receptor-related protein 6 (LRP6) |